Regenxbio
RGNX
69 hedge funds and large institutions have $147M invested in Regenxbio in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 6 closing their positions.
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
8% more funds holding
Funds holding: 64 → 69 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $180M → $147M (-$32.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$7.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$7.07M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.67M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$3.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.8M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$4.57M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.47M |
| 4 |
VAM
Visium Asset Management
New York
|
-$2.21M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.37M |
RGNX Hedge Fund Activity: Q2 2016 in Review
69 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2016, worth a combined $147M — down 18% from $180M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RGNX positions and 6 closed out — a net gain of 5 holders — while 36 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $7.6M. The largest seller was Fidelity Investments, cutting an estimated $12.8M.
- 69 institutional investors held Regenxbio (RGNX) as of Q2 2016, up from 64 in Q1 2016.
- Funds reported $147M of Regenxbio stock for Q2 2016, down 18% quarter-over-quarter.
- 11 funds opened new Regenxbio positions in Q2 2016 and 6 closed out, a net change of +5 holders.
- The largest Regenxbio buyer in Q2 2016 was BlackRock Advisors, an estimated $7.6M added.
- The largest Regenxbio seller in Q2 2016 was Fidelity Investments, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2016.